Morning Briefing
Summaries of health policy coverage from major news organizations
GAVI Alliance To Fund Roll-Out Of Vaccines Against Cervical Cancer, Rubella in Developing Countries
The GAVI Alliance "has agreed to fund the roll-out of vaccines against cervical cancer in developing countries, offering protection against a disease that kills one woman every two minutes," Reuters reports (Hirschler, 11/17). The group is continuing negotiations with pharmaceutical companies to lower the price of the vaccine, NPR's health blog "Shots" notes. "By 2015, GAVI expects that two million girls in nine countries will have received the HPV vaccine," but the shot will not be given to boys unless the WHO recommends they also receive the immunization, according to the blog (Husted, 11/17).
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
